CH Biotech R&D Co (TPE:6534) Accounts Payable & Accrued Expense : NT$650 Mil (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is CH Biotech R&D Co Accounts Payable & Accrued Expense?

CH Biotech R&D Co's quarterly accounts payable & accrued expense increased from Sep. 2024 (NT$211 Mil) to Dec. 2024 (NT$222 Mil) and increased from Dec. 2024 (NT$222 Mil) to Mar. 2025 (NT$650 Mil).

CH Biotech R&D Co's annual accounts payable & accrued expense increased from Dec. 2022 (NT$203 Mil) to Dec. 2023 (NT$276 Mil) but then declined from Dec. 2023 (NT$276 Mil) to Dec. 2024 (NT$222 Mil).

CH Biotech R&D Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for CH Biotech R&D Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CH Biotech R&D Co Accounts Payable & Accrued Expense Chart

CH Biotech R&D Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

95.41

180.01

202.63

276.24

222.06

CH Biotech R&D Co Quarterly Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															667.76	272.57	210.66	222.06	649.74

CH Biotech R&D Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

CH Biotech R&D Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » CH Biotech R&D Co Ltd (TPE:6534) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 89, Wenxian Road, Nantou County, Nantou, TWN, 540001

Website

https://www.chbio.com.tw

CH Biotech R&D Co Ltd is a Taiwan-based company engaged in the manufacture and sales of fertilizer, as well as providing biotechnology services. It is engaged in the research, development, manufacturing, and sales of proprietary plant growth regulators and specialty micronutrient fertilizers. It offers NutriSync 3D plant growers in the form of boron and molybdenum, NutriSync D liquid formulation for dicot crops, CHB-HS for reducing carbon emissions in crop production, CHB-BB2, fruit quality enhancers, and other related products. The company has one reportable segment, Agricultural Biotechnology. Geographically, it derives maximum revenue from the United States, and the rest from other countries.

CH Biotech R&D Co Headlines

No Headlines